We are live on ! Find out more
IRD

Opus Genetics
IRD

37 hedge funds and large institutions have $5.69M invested in Opus Genetics in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $4.62M → $5.69M (+$1.06M)

1.3% more ownership

Funds ownership: 12.44% → 13.73% (+1.3%)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

3% less funds holding

Funds holding: 38 → 37 (-1)

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

Holders
37
Holders Change
-1
Holders Change %
-2.63%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
9
Closed
6
Calls
$690K
Puts
–
Net Calls
+$690K
Net Calls Change
-$74K

Top Buyers

Rank Fund Capital Flow
1
MCM
MAI Capital Management
Ohio
+$770K
2
RHJA
Rice Hall James & Associates
California
+$459K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$55.2K
4
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$38.8K
5
JP Morgan Chase
JP Morgan Chase
New York
+$33.7K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
-$290K
2
Citadel Advisors
Citadel Advisors
Florida
-$35.5K
3
PCM
Prelude Capital Management
New York
-$34K
4
Millennium Management
Millennium Management
New York
-$24K
5
DC
Diametric Capital
Massachusetts
-$21.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
SFO
26
Stokes Family Office
Louisiana
$24K – – –
KPWS
27
Kestra Private Wealth Services
Texas
$20K – – –
TRCT
28
Tower Research Capital (TRC)
New York
$7K +$552 +256 +8%
Wells Fargo
29
Wells Fargo
California
$6K +$9 +4 +0.1%
UBS Group
30
UBS Group
Switzerland
$3K -$1.65K -766 -31%
CAL
31
Capital Analysts LLC
Pennsylvania
$3K +$3.53K +1,636 New
CWM
32
CarsonAllaria Wealth Management
Illinois
$2K – – –
APC
33
Aspire Private Capital
North Carolina
$1K – – –
First Manhattan
34
First Manhattan
New York
$1K – – –
PCM
35
Prelude Capital Management
New York
– -$34K -17,802 Closed
Citadel Advisors
36
Citadel Advisors
Florida
– -$35.5K -16,458 Closed
MA
37
MCF Advisors
Kentucky
– -$20K -10,565 Closed
KAS
38
Kestra Advisory Services
Texas
– -$19K -10,005 Closed
SWM
39
Spire Wealth Management
Virginia
– -$17K -9,002 Closed
Osaic Holdings
40
Osaic Holdings
Arizona
– -$18.8K -8,723 -99%
1
2

IRD Hedge Fund Activity: Q3 2022 in Review

37 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q3 2022, worth a combined $5.69M — up 23% from $4.62M a quarter earlier.

Fund positioning in IRD was balanced in Q3 2022: 6 funds opened new positions, 6 closed out, 7 added to existing stakes and 9 trimmed.

The largest buyer was MAI Capital Management, opening a new position worth an estimated $770K. The largest seller was Two Sigma Advisers, cutting an estimated $290K.

  • 37 institutional investors held Opus Genetics (IRD) as of Q3 2022, down from 38 in Q2 2022.
  • Funds reported $5.69M of Opus Genetics stock for Q3 2022, up 23% quarter-over-quarter.
  • 6 funds opened new Opus Genetics positions in Q3 2022 and 6 closed out, a net change of 0 holders.
  • The largest Opus Genetics buyer in Q3 2022 was MAI Capital Management, an estimated $770K added.
  • The largest Opus Genetics seller in Q3 2022 was Two Sigma Advisers, an estimated $290K sold.

Based on aggregated 13F filings for Q3 2022.